preloder

INVEST INTO LONGEVITY

Full Range of Living Conditions for Longevity
We know How To Improve Your Life Now
Become part of a decentralized ecosystem
GLOBAL LONGEVITY

Private ICO round successfully completed!

TRADE LONGEVITY TOKEN ON:

NEXT LISTING
COMING SOON
ABOUT PROJECT
Global longevity is a decentralized, scalable ecosystem that creates a full spectrum of living conditions for quality longevity. It uses all the latest achievements of world science and works on the IT platform for the personalized management of life span based on blockchain, neural networks and machine learning.
The Longevity software token is generated by Global Longevity and provides its owners with access to the company’s current and future services. Global Longevity embodies the best technologies and years of experience in the longevity market.

Longevity is Utility Token

Being a non-financial tool, it provides owners with access to Global Longevity services and products that can be purchased at the Global Longevity Market.

Our Mission

The mission of Global Longevity is to give people a real opportunity to extend life through the use of advanced science of longevity technology.

Become part of a decentralized ecosystem

GLOBAL LONGEVITY

0
5

CONTINENTS

0
18

COUNTRIES

0
256

INVESTORS

0
36

PARTNERS

0
122

EMPLOYEES

Ukraine
Singapore
Germany
Georgia
Israel
China
Mexico
Sri Lanka
Brazil
Turkey
Ecuador
Peru
South Africa
Argentina
Vietnam
India
Costa Rica
Australia

DO NOT BE A GUEST IN LIFE

BECOME HER HOST!

I decided to live forever. And so far everything goes well.

Unknown Author

THAT CAN BE PURCHASED FOR LONGEVITY

Apartments and Land near the sea (purchase and rental)

Wishing to buy property in attractive resort and recreational areas also opens up broad prospects and opportunities. Especially popular among foreign citizens is the region of Georgia – Ajaria, and in particular the city of Batumi – a port city, where they go for a unique flavor.

Diagnosis and Treatment

A complete diagnosis of the body means a comprehensive examination, which is carried out with the help of special devices and through the delivery of various tests. The data obtained allow us to make a complete picture of the state of human health, its internal organs and new formations, both benign and malignant.

Legal Assistance

The high efficiency of the services provided is due to the principles that guide us. This is a professional level of lawyers training, personal approach to each client, responsibility for the quality of services, focus on the wishes and interests of their principals.

Pharmacological Products

This industry is related to research, development, mass production, market research and distribution of medicines, mainly intended for the prevention, relief and treatment of diseases. Currently, the pharmaceutical industry is one of the most successful industries.

Organic Food Products for GLOBAL LONGEVITY

All over the world, the production of organic food is booming. This food contains on average 10–50% more vitamins, minerals and other nutrients compared to products produced by modern technologies. Organic food improves health, boosts immunity, and especially it is useful for children, pregnant women and nursing mothers.

Tourist Services

If you like to breathe fresh wind, wake up to the birds singing and the murmur of the stream, you want to plunge into the wonderful world of adventure – you have come to the right place!

Mining

Global Longevity’s experience in this field has helped us build partnerships with leading equipment manufacturers and technology companies, which will allow us to successfully and profitably help our customers to carry out mining operations in the future.

ICO & STO Promotion

One can achieve all the goals successfully only when the professional skills are properly combined. Every member of our team is a skilled professional, who concentrates on the scope.

Absolutely the entire volume of issued tokens is fully provided with goods and services that are provided in our Global Longevity Market even if the cost of 1 Longevity (0,00001 ETH) is equal to 0,001 ETH. Thus, today the initial growth potential of the token is 9900%.
Name: LONGEVITY
Ticker: LGV
Type: ERC-20
Platform: Ethereum
Token Type: Utility
Token Price: 0,00001 ETH
Soft Cap: none
Hard Cap: 1.000.000 LGV
Return on Invest: long-term token value increase
Purchase methods accepted: All Leading Crypto and Fiat
Total token supply: 100.000.000.000 LGV
Private-sale & Public Sale: 89.000.000.000 LGV
Team: 5.000.000.000 LGV
Advisors: 3.000.000.000 LGV
Marketing Activities and Bounty: 3.000.000.000 LGV

PERCENTAGE OF TOKENS DISTRIBUTION

ALLOCATING AND USING FUNDS

NOTES

  • Team’s token will be locked for 30 months after the Private-sale & Public Sale
  • Tokens for Marketing team and Bounty will be locked for 6 months after the Private-sale & Public Sale
Investor Exclusions: Afghanistan, Angola, Aruba, Australia, Bangladesh, Belarus, Benin, Bhutan, Bolivia, Botswana, Brunei Darussalam, Burkina Faso, Bosnia, Burundi, Cambodia, Cameroon, Canada, Cape Verde, Central Africa republic, Chad, China, Comoros, Congo, Congo Democratic republic, Cuba, Cote d´lvoire, Djibouti, Dominica, Ecuador, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guatemala, Guyana, Guinea, Guinea Bissau, Haiti, Honduras, Iran, Iraq, Japan, Jordan, Kenya, Kyrgytz Republic, Laos, People’s Republic, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Micronesia, Moldova, Mongolia, Mozambique, Myanmar, Nauru, Nepal, New Caledonia, Nicaragua, Niger, Nigeria, Niue, North Korea, Oman, Pakistan, Palestinian Areas, Papua New Guinea, Republic of Korea, Reunion, Rwanda, Samoa, Sao Tome and Principe, Senegal, Sierra Leone, Somalia, South Georgia, Sudan, Sri Lanka, Suriname, Syria, Swaziland, Tajikistan, Tanzania, Timor, Togo, Tonga, Tunisia, Turkmenistan, Uganda, United States, Uzbekistan, Venezuela, Western Sahara, Yemen, Zambia.
ROADMAP
Jan 2014
Official opening Global Longevity Institute
Mar 2014
Approval of the concept of creating an ecosystem within the program of Global Longevity
Nov 2014
Selection and approval of the region for the pilot project of Global Longevity
Jan 2015
Initiation of a material base for a pilot project of Global Longevity
May 2017
Completion of work on the creation of a material basis for the pilot project of Global Longevity
Jul 2017
Deciding on the implementation of blockchain and cryptocurrency in the project of Global Longevity
Jan 2018
Start preparation for ICO Global Longevity
Dec 2018
Cryptocurrency issue Longevity
May 2019
Start Pre ICO
Jun 2019
Start ICO
Jul 2021
Full launch of the Global Longevity project
TEAM & ADVISORS

Elina Mahzhalii

CEO (Chief Executive Officer),
CEO Global Longevity Institute

Wolfgang Stremmel

Professor of Internal Medicine IV

Soeharto Lee

Professor of Medicine, Longevity Technology Expert

Akaki Lomadze

Doctor of Medicine, Male Health Expert

Denys Matsepliuk

CIO (Chief Information Officer)

IT manager, information technology director, responsible for the acquisition and implementation of new technologies, information resources management.

Jīnlóng Xiàng

CLO (Chief Legal Officer)

Manager of legal informatization, director of legislative technologies. Advisor to the corporation, executive of the highest rank, responsible for the legal support of contracts, expert in cryptocurrency legislation.

Champ Janadar

CMO (Chief Marketing Officer)

Consultant in marketing and marketing strategy of the enterprise, manages the work of the marketing service of the enterprise.

Guāngmíng Bō

One of the leaders of the travel direction of the corporation, responsible for its development and development of new tourism products.

MAKE A STEP TOWARDS TO

LONGEVITY!

PARTNERS
LATEST NEWS
January 2020
According to the planned Global Longevity project order, the international audit company began work on a large-scale audit study of all project assets (preliminary total cost of about $ 25 000 000), their assessment expertise with analysis of the growth prospects of the project assets. The final conclusion will be available soon.
December 2019
Happy New Year and Merry Christmas to all project staff and partners!
November 2019
In accordance with the plan for the development of Global Longevity PharmaceuticalsTM, we invested the project funds in a new pharmacological complex located in an alpine forest region with a huge range of high-quality medicinal plants and herbs.
August 2019
In the near future we will be publishing the latest scientific article by the CEO Global Longevity Elina Manzhalii on the fundamental scientific foundations of the Global Longevity project, as well as her large interview on the development of the project to one of the world profile publications.
August 2019
During the private ICO stage, institutional investors acquired 2 billion LGV, while receiving a 10% bonus.
GET IN TOUCH WITH US

 

Global Longevity Disclaimer

Potentially interested parties should note that participation in the Global Longevity project is subject to limitations imposed by applicable securities laws in various jurisdictions.

Potential investors should note that participation in the Global Longevity Sale is subject to limitations imposed by applicable securities laws in various jurisdictions. The following does neither constitute an offer to buy or to subscribe for the Potentially interested parties should note that participation in the Global Longevity project is subject to limitations imposed by applicable securities laws in various jurisdictions.

Potential investors should note that participation in the Global Longevity project Sale is subject to limitations imposed by applicable securities laws in various jurisdictions. The following does neither constitute an offer to buy or to subscribe for the Global Longevity project. Investors should make their decision to buy or to subscribe to Global Longevity project.

Investors are furthermore advised to consult their bank or financial adviser before making any investment decision. This publication may contain specific forward-looking statements, e.g. statements including terms like “believe”, assume”, “expect”, “forecast”, “project”, “may”, “could”, “might”, “will” or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of the company and those explicitly or implicitly presumed in these statements.

Against the background of these uncertainties, readers should not rely on forward-looking statements. Global Longevity project assumes no responsibility to update forward-looking statements or to adapt them to future events or developments. The information contained herein shall not constitute an offer to sell or the solicitation of an offer to buy, in any jurisdiction in which such offer or solicitation would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any jurisdiction.

The Global Longevity project are not for sale and distribution, directly or indirectly, in or into the United States (including its territories and dependencies, any state of the United States and the District of Columbia), Canada, Japan, Australia, North Korea, Iran, Myanmar, Afghanistan, Angola, Aruba, Bangladesh, Belarus, Benin, Bhutan, Bolivia, Botswana, Brunei Darussalam, Burkina Faso, Bosnia, Burundi, Cambodia, Cameroon, Cape Verde, Central Africa republic, Chad, Comorros, Congo, Congo Democratic republic, Cuba, Cote d’Ivoire, Djibouti, Dominica, Ecuador, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guatemala, Guyana, Guinea, Guinea Bissau, Haiti, Honduras, Iraq, Jordan, Kenya, Kyrgyz Republic, Laos People’s Republic, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Micronesia, Moldova, Mongolia, Mozambique, Nauru, Nepal, New Caledonia, Nicaragua, Niger, Nigeria, Niue, Oman, Pakistan, Palestinian Areas, Papua New Guinea, Reunion, Rwanda, Samoa, Sao Tome and Principe, Senegal, Sierra Leone, Somalia, South Georgia, Sudan, Sri Lanka, Suriname, Syria, Swaziland, Tajikistan, Tanzania, Timor, Togo, Tonga, Tunisia, Turkmenistan, Uganda, Uzbekistan, Venezuela, Western Sahara, Yemen, Zambia, Zimbabwe or any jurisdiction into which the same would be unlawful.

This announcement does not constitute or form a part of any offer or solicitation to purchase, subscribe for or otherwise acquire securities in the United States, Canada, Japan, Australia, North Korea, Iran, Myanmar,Afghanistan, Angola, Aruba, Bangladesh, Belarus, Benin, Bhutan, Bolivia, Botswana, Brunei Darussalam, Burkina Faso, Bosnia, Burundi, Cambodia, Cameroon, Cape Verde,Central Africa republic, Chad, Comorros, Congo, Congo Democratic republic, Cuba, Cote d’Ivoire, Djibouti, Dominica, Ecuador, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guatemala, Guyana, Guinea, Guinea Bissau, Haiti, Honduras, Iraq, Jordan, Kenya, Kyrgyz Republic, Laos People’s Republic, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Micronesia, Moldova, Mongolia, Mozambique, Nauru, Nepal, New Caledonia, Nicaragua, Niger, Nigeria, Niue, Oman, Pakistan, Palestinian Areas, Papua New Guinea, Reunion, Rwanda, Samoa, Sao Tome and Principe, Senegal, Sierra Leone, Somalia, South Georgia, Sudan, Sri Lanka, Suriname, Syria, Swaziland, Tajikistan, Tanzania, Timor, Togo, Tonga, Tunisia, Turkmenistan, Uganda, Uzbekistan, Venezuela, Western Sahara, Yemen, Zambia, Zimbabwe or any jurisdiction in which such an offer or solicitation is unlawful.

The Global Longevity project will not be registered under the US Securities Act of 1933, as amended or under any securities laws of any state or other jurisdiction of the United States and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within the United States.

The Global Longevity project have not been approved or disapproved by the US Securities and Exchange Commission, any state’s securities commission in the United States or any US regulatory authority, nor have any of the foregoing authorities passed upon or endorsed the merits of the offering of the Global Longevity project or the accuracy or adequacy of this announcement. Any representation to the contrary is a criminal offence in the United States. The information contained herein does not constitute an offer of securities to the public in the United Kingdom. No prospectus offering securities to the public will be published in the United Kingdom.

This document is only being distributed to and is only directed at (i) persons who are outside the United Kingdom or (ii) to investment professionals falling within article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”) or (iii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within article 49(2)(a) to (d) of the Order (all such persons together being referred to as “relevant persons”). The Global Longevity project are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such the Global Longevity project will be engaged in only with, relevant persons.

Any person who is not a relevant person should not act or rely on this document or any of its contents. Any offer of securities to the public that may be deemed to be made pursuant to this communication in any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the “Prospectus Directive”) is only addressed to qualified investors in that Member State within the meaning of the Prospectus Directive.